Cingulate Stock Performance
CING Stock | USD 5.73 0.07 1.24% |
On a scale of 0 to 100, Cingulate holds a performance score of 9. The firm shows a Beta (market volatility) of 0.7, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Cingulate's returns are expected to increase less than the market. However, during the bear market, the loss of holding Cingulate is expected to be smaller as well. Please check Cingulate's sortino ratio, skewness, period momentum indicator, as well as the relationship between the potential upside and rate of daily change , to make a quick decision on whether Cingulate's price patterns will revert.
Risk-Adjusted Performance
OK
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Cingulate are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly abnormal basic indicators, Cingulate reported solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 9.48 | Five Day Return 18.66 | Year To Date Return 10.98 | Ten Year Return (99.47) | All Time Return (99.47) |
Last Split Factor 1:12 | Last Split Date 2024-08-09 |
1 | Cingulate Announces Positive Top-Line Results from High-Dose FedFast Study of Lead Asset CTx-1301 for ADHD | 04/29/2025 |
2 | Cingulate Inc Terminates Grant Agreement with Foundation - TipRanks | 05/13/2025 |
3 | CING Roth Capital Lowers Price Target, Maintains Buy Rating CING Stock News | 05/19/2025 |
4 | Efficacy Results Announced from Cingulates Phase 3 Pediatric Study of CTx-1301 for ADHD | 05/20/2025 |
5 | CING Ascendiant Capital Raises Price Target to 61.00 CING Stock News | 05/27/2025 |
6 | Stonegate Capital Partners Initiates Coverage on Cingulate Inc. CING Stock News | 06/18/2025 |
7 | Acquisition by Werth Peter J. of 15000 shares of Cingulate at 4.14 subject to Rule 16b-3 | 06/20/2025 |
8 | Acquisition by Silva Raul R. of 1000 shares of Cingulate at 4.07 subject to Rule 16b-3 | 06/30/2025 |
9 | Acquisition by Brams Matthew of 52500 shares of Cingulate at 4.42 subject to Rule 16b-3 | 07/07/2025 |
10 | Insider Trading | 07/08/2025 |
11 | Cingulate Appoints Nilay Patel as Chief Legal Officer Amid FDA Plans CING Stock News | 07/09/2025 |
Begin Period Cash Flow | 52.4 K | |
Total Cashflows From Investing Activities | -211.8 K |
Cingulate | Build AI portfolio with Cingulate Stock |
Cingulate Relative Risk vs. Return Landscape
If you would invest 425.00 in Cingulate on April 23, 2025 and sell it today you would earn a total of 131.50 from holding Cingulate or generate 30.94% return on investment over 90 days. Cingulate is currently generating 0.5253% in daily expected returns and assumes 4.2881% risk (volatility on return distribution) over the 90 days horizon. In different words, 38% of stocks are less volatile than Cingulate, and 90% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
Risk |
Cingulate Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cingulate's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Cingulate, and traders can use it to determine the average amount a Cingulate's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1225
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | CING | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
4.29 actual daily | 38 62% of assets are more volatile |
Expected Return
0.53 actual daily | 10 90% of assets have higher returns |
Risk-Adjusted Return
0.12 actual daily | 9 91% of assets perform better |
Based on monthly moving average Cingulate is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cingulate by adding it to a well-diversified portfolio.
Cingulate Fundamentals Growth
Cingulate Stock prices reflect investors' perceptions of the future prospects and financial health of Cingulate, and Cingulate fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Cingulate Stock performance.
Return On Equity | -3.58 | ||||
Return On Asset | -1.14 | ||||
Current Valuation | 17.51 M | ||||
Shares Outstanding | 4.25 M | ||||
Price To Book | 3.70 X | ||||
Gross Profit | (9.86 M) | ||||
EBITDA | (15.64 M) | ||||
Net Income | (15.55 M) | ||||
Cash And Equivalents | 8.2 M | ||||
Cash Per Share | 0.73 X | ||||
Total Debt | 5.1 M | ||||
Debt To Equity | 0.08 % | ||||
Current Ratio | 10.94 X | ||||
Book Value Per Share | 1.55 X | ||||
Cash Flow From Operations | (18.45 M) | ||||
Earnings Per Share | (4.41) X | ||||
Market Capitalization | 24.03 M | ||||
Total Asset | 14.86 M | ||||
Retained Earnings | (108.49 M) | ||||
Working Capital | 7.69 M | ||||
About Cingulate Performance
By analyzing Cingulate's fundamental ratios, stakeholders can gain valuable insights into Cingulate's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Cingulate has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Cingulate has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Last Reported | Projected for Next Year | ||
Days Of Inventory On Hand | (10.53) | (10.00) | |
Return On Tangible Assets | (1.05) | (1.10) | |
Return On Capital Employed | (1.58) | (1.66) | |
Return On Assets | (1.05) | (1.10) | |
Return On Equity | (2.09) | (2.19) |
Things to note about Cingulate performance evaluation
Checking the ongoing alerts about Cingulate for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Cingulate help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Cingulate appears to be risky and price may revert if volatility continues | |
Cingulate has high likelihood to experience some financial distress in the next 2 years | |
Net Loss for the year was (15.55 M) with loss before overhead, payroll, taxes, and interest of (9.86 M). | |
Cingulate currently holds about 8.2 M in cash with (18.45 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.73. | |
Cingulate has a frail financial position based on the latest SEC disclosures | |
Latest headline from gurufocus.com: Cingulate Appoints Nilay Patel as Chief Legal Officer Amid FDA Plans CING Stock News |
- Analyzing Cingulate's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Cingulate's stock is overvalued or undervalued compared to its peers.
- Examining Cingulate's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Cingulate's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Cingulate's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Cingulate's stock. These opinions can provide insight into Cingulate's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Cingulate Stock analysis
When running Cingulate's price analysis, check to measure Cingulate's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cingulate is operating at the current time. Most of Cingulate's value examination focuses on studying past and present price action to predict the probability of Cingulate's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cingulate's price. Additionally, you may evaluate how the addition of Cingulate to your portfolios can decrease your overall portfolio volatility.
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Global Correlations Find global opportunities by holding instruments from different markets | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |